Skip Navigation

Cardiovascular Research 2007 76(2):213-223; doi:10.1016/j.cardiores.2007.06.032
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ho, T.-C.
Right arrow Articles by Tsao, Y.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, T.-C.
Right arrow Articles by Tsao, Y.-P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells

T.-C. Hoa, S.-L. Chenb, Y.-C. Yanga,c,d, C.-L. Liaoe, H.-C. Chengf and Y.-P. Tsaoa,e,f,*

aDepartments of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
bDepartment of Microbiology, School of Medicine, National Taiwan University, Taipei, Taiwan
cMackay Medicine, Nursing and Management College, Taipei, Taiwan
dSchool of Medicine, Taipei Medical University, Taipei, Taiwan
eDepartment of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan
fDepartment of Ophthalmology, Mackay Memorial Hospital, Taipei, Taiwan

*Corresponding author. Tel.: +886 2 28094661x3076; fax: +886 2 28085952. yptsao{at}yahoo.com

Objective Pigment epithelial-derived factor (PEDF) is a potent anti-angiogenic factor whose effects are partially mediated through the induction of endothelial cell apoptosis. The pathway mediating endothelial cell apoptosis has not been fully established. Here we investigated the participation of peroxisome proliferator-activated receptor {delta} (PPAR{delta}) and p53 in the apoptosis of human umbilical vein endothelial cells (HUVECs).

Methods and results HUVECs pretreated with either PPAR{delta} antagonist or PPAR{delta} small interfering RNA (siRNA) suppressed PEDF-induced apoptosis as determined by TUNEL assay, annexin V-FITC/PI staining, and cleavage of procaspase-8, -9, -3. PEDF sequentially induced PPAR{delta} and p53 expression as observed in immunoblotting and immunofluoresence assays. PEDF also increased the transcriptional activity of PPAR{delta} as evident from electromobility shift assays, and p53 as determined by the phosphorylation and acetylation of p53 and the induction of Bax. The induction of p53 by PEDF was abolished by either PPAR{delta} antagonist or PPAR{delta} siRNA. PEDF-mediated HUVEC apoptosis and cleavage of procaspases were significantly attenuated by p53 siRNA.

Conclusions Our observations indicate that PEDF induces HUVECs apoptosis through the sequential induction of PPAR{delta} and p53 overexpression. With the growing interest in anti-angiogenesis as a novel approach to cancer therapy, defining the mechanism of PEDF-mediated HUVEC apoptosis may facilitate the development of new therapeutics.

KEYWORDS PEDF; Apoptosis; HUVEC; PPAR gamma; p53


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
T. Tsuzuki and Y. Kawakami
Tumor angiogenesis suppression by {alpha}-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via peroxisome proliferator-activated receptor {gamma}
Carcinogenesis, April 1, 2008; 29(4): 797 - 806.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.